Matrix metalloproteinase-1 and -3 in breast cancer: Correlation with progesterone receptors and other clinicopathologic features
- 1 April 1999
- journal article
- Published by Elsevier in Human Pathology
- Vol. 30 (4) , 436-442
- https://doi.org/10.1016/s0046-8177(99)90120-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinomaThe Journal of Pathology, 1997
- Expression of Interstitial Collagenase (Matrix Metalloproteinase-1) in Gastric CancersJapanese Journal of Cancer Research, 1997
- High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinomaInternational Journal of Cancer, 1996
- Expression of Immunoreactive Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Human Normal Livers and Primary Liver TumorsHepatology, 1996
- Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblastsBritish Journal of Cancer, 1995
- Metalloproteinase and timp expression by the human breast carcinoma cell line 8701‐BCInternational Journal of Cancer, 1993
- Production onf matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic studyCancer, 1992
- Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomasBritish Journal of Cancer, 1992
- Membrane proteases: roles in tissue remodeling and tumour invasionCurrent Opinion in Cell Biology, 1992
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981